{"id":42783,"date":"2024-01-05T18:00:00","date_gmt":"2024-01-05T17:00:00","guid":{"rendered":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/"},"modified":"2024-01-05T18:00:00","modified_gmt":"2024-01-05T17:00:00","slug":"ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7","status":"publish","type":"press_release","link":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/","title":{"rendered":"Ipsen &#8211; Monthly information relative to the total number of voting rights and shares composing the share capital"},"content":{"rendered":"<p align=\"center\"><strong>Monthly information relative to the total number of voting rights <\/strong><br \/><strong>and shares composing the share capital <\/strong><\/p>\n<p align=\"center\">(in accordance with Article L.233-8 II of the French Commercial Code and <br \/>Article 223-16 of the General Regulation of the <em>Autorit\u00e9 des March\u00e9s Financiers<\/em>) <\/p>\n<p align=\"left\">Market: Euronext Paris <br \/>ISIN Code: FR 0010259150<br \/>LEI: 549300M6SGDPB4Z94P11<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"width:27.2%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle\"><strong>Date<\/strong><\/td>\n<td style=\"width:25.08%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\"><strong>Total number of shares composing the share capital<\/strong><\/td>\n<td style=\"width:47.72%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\"><strong>Total number of voting rights <sup>(1)<\/sup><\/strong><\/td>\n<\/tr>\n<tr>\n<td rowspan=\"2\" style=\"width:27.2%;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle\">31 December 2023<\/td>\n<td rowspan=\"2\" style=\"width:25.08%;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\">83,814,526<\/td>\n<td style=\"width:47.72%;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\">Gross total* of voting rights: 132,105,196<\/td>\n<\/tr>\n<tr>\n<td style=\"width:47.72%;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\">Net total** of voting rights: 130,988,880<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\"><sup>(1)<\/sup> Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10).<\/p>\n<p align=\"justify\">* Gross total\u00a0= total number of voting rights attached to the total number of shares, including the number of shares which benefit of double voting rights and the number of treasury shares. The \u00ab\u00a0Gross total\u00a0\u00bb is used as a basis for the calculation of threshold crossings.<\/p>\n<p align=\"justify\">** Net total = total number of voting rights attached to the total number of shares \u2013 shares without voting rights.<\/p>\n<p id=\"gnw_attachments_section-header\">\n    <strong>Attachment<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=y0btT4xZUmzdfWUW2PxLZn4zWyYB8QMvhJZs5QvEOuOM3u_r7AqSD0OxHMzkpv9dxnuot0OA54SMRIkmJrP_adCFFibGN8amnc1FyXJz3Qb3sgJwwSUN8jrReV06sYiV2VWOTx2dJ8JWF4rh95bp9BU86V2_hvGPf36nVRTfvsDWT0Rbbtir69kfyaSObget5ZLeVHcDHQuRw_iHGCJJ_8TW8CXXqKRfFFsbycTKk4uK1sqvO9GOFbwH7dmhAT4N\" title=\"Declaration relative to the total number of voting rights - December 2023\" rel=\"nofollow noopener\">Declaration relative to the total number of voting rights &#8211; December 2023 <\/a>\n      <\/li>\n<\/ul>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[1771],"tags":[],"class_list":["post-42783","press_release","type-press_release","status-publish","hentry","category-regulated-info","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital - Global<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital - Global\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/\",\"name\":\"Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital - Global\",\"isPartOf\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\",\"datePublished\":\"2024-01-05T17:00:00+00:00\",\"dateModified\":\"2024-01-05T17:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen &#8211; Monthly information relative to the total number of voting rights and shares composing the share capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/#website\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/04\/17170708\/Logo_IPSEN.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/04\/17170708\/Logo_IPSEN.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital - Global","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital - Global","og_url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/","og_site_name":"Global","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/","name":"Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital - Global","isPartOf":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#primaryimage"},"image":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png","datePublished":"2024-01-05T17:00:00+00:00","dateModified":"2024-01-05T17:00:00+00:00","breadcrumb":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/ODM2ZjY3ZjYtMmExMi00ZWY4LWFkMjYtOGEwMzMwNGY5Yjg1LTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png"},{"@type":"BreadcrumbList","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d3glparxwv1yl3.cloudfront.net\/"},{"@type":"ListItem","position":2,"name":"Ipsen &#8211; Monthly information relative to the total number of voting rights and shares composing the share capital"}]},{"@type":"WebSite","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/#website","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/","name":"Global","description":"","publisher":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d3glparxwv1yl3.cloudfront.net\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/#organization","name":"IPSEN","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/04\/17170708\/Logo_IPSEN.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/04\/17170708\/Logo_IPSEN.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-json\/wp\/v2\/press_release\/42783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-json\/wp\/v2\/press_release\/42783\/revisions"}],"wp:attachment":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-json\/wp\/v2\/media?parent=42783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-json\/wp\/v2\/categories?post=42783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-json\/wp\/v2\/tags?post=42783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}